Discontinued — last reported Q4 '21
Accrued Contingent Liabilities
ResMed Accrued Contingent Liabilities remained flat by 0.0% to $800.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $700.00K to $800.00K. Over 3 years (FY 2022 to FY 2025), Accrued Contingent Liabilities shows a downward trend with a -69.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past uncertainties.
Detailed definition
This represents the estimated financial obligations arising from past events where the outcome is uncertain but probable...
Peer comparison
Peers typically disclose these in legal contingencies footnotes; high levels relative to equity can signal significant litigation exposure.
accrued_contingent_liabilitiesHistorical Data
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.20M | $22.40M | $24.10M | $29.70M | $32.60M | $28.90M | $29.20M | $35.00M | $800.00K | $800.00K | $700.00K | $700.00K | $700.00K | $700.00K | $800.00K | $800.00K |
| QoQ Change | — | -7.4% | +7.6% | +23.2% | +9.8% | -11.3% | +1.0% | +19.9% | -97.7% | +0.0% | -12.5% | +0.0% | +0.0% | +0.0% | +14.3% | +0.0% |
| YoY Change | — | — | — | — | +34.7% | +29.0% | +21.2% | +17.8% | -97.5% | -97.2% | -97.6% | -98.0% | -12.5% | -12.5% | +14.3% | +14.3% |
Accrued Contingent Liabilities at Other Companies
Frequently Asked Questions
- What is ResMed's accrued contingent liabilities?
- ResMed (RMD) reported accrued contingent liabilities of $800.00K in Q1 2026.
- How has ResMed's accrued contingent liabilities changed year-over-year?
- ResMed's accrued contingent liabilities increased by 14.3% year-over-year, from $700.00K to $800.00K.
- What is the long-term trend for ResMed's accrued contingent liabilities?
- Over 3 years (2022 to 2025), ResMed's accrued contingent liabilities has grown at a -69.3% compound annual growth rate (CAGR), from $24.20M to $700.00K.
- What does accrued contingent liabilities mean?
- The amount of money set aside to cover potential future losses from uncertain events like legal disputes.